COVID-19Trade PolicyTRIPSTRIPS Flexibilities Working with the Ministerial Decision on TRIPSJuly 3, 2022 In the short amount of time since it was made public, the Ministerial Decision on…Praharsh Gour COVID-19Trade PolicyTRIPSTRIPS Flexibilities Ministerial Decision: “TRIPped” the Waiver?June 27, 2022 The 12th Ministerial Conference (MC12) concluded on Friday, June 17, 2022, with a “Ministerial Decision…Shirin Syed PatentsRight to HealthTRIPS Flexibilities Increasing Access to Medicines in Black Communities by Taking Advantage of Doha FlexibilitiesNovember 10, 2021 There is no legitimate reason for anyone in America to go without affordable access to…Myeshia Shelby COVID-19TRIPSTRIPS Flexibilities The Overlooked Role of Copyright in Securing Vaccine Distribution EquitySeptember 6, 2021 As the COVID-19 pandemic continues to ravage the globe, we need to consider every avenue…Doris Estelle Long TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long COVID-19PatentsTRIPSTRIPS Flexibilities Getting Serious About Grey Market Imports in the Fight Against COVID-19May 18, 2020 Since the HIV/AIDS pandemic of the 1990s, allowing the importation of generic “grey market” versions…Doris Estelle Long Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19Trade PolicyTRIPSTRIPS Flexibilities Ministerial Decision: “TRIPped” the Waiver?June 27, 2022 The 12th Ministerial Conference (MC12) concluded on Friday, June 17, 2022, with a “Ministerial Decision…Shirin Syed PatentsRight to HealthTRIPS Flexibilities Increasing Access to Medicines in Black Communities by Taking Advantage of Doha FlexibilitiesNovember 10, 2021 There is no legitimate reason for anyone in America to go without affordable access to…Myeshia Shelby COVID-19TRIPSTRIPS Flexibilities The Overlooked Role of Copyright in Securing Vaccine Distribution EquitySeptember 6, 2021 As the COVID-19 pandemic continues to ravage the globe, we need to consider every avenue…Doris Estelle Long TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long COVID-19PatentsTRIPSTRIPS Flexibilities Getting Serious About Grey Market Imports in the Fight Against COVID-19May 18, 2020 Since the HIV/AIDS pandemic of the 1990s, allowing the importation of generic “grey market” versions…Doris Estelle Long Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
PatentsRight to HealthTRIPS Flexibilities Increasing Access to Medicines in Black Communities by Taking Advantage of Doha FlexibilitiesNovember 10, 2021 There is no legitimate reason for anyone in America to go without affordable access to…Myeshia Shelby COVID-19TRIPSTRIPS Flexibilities The Overlooked Role of Copyright in Securing Vaccine Distribution EquitySeptember 6, 2021 As the COVID-19 pandemic continues to ravage the globe, we need to consider every avenue…Doris Estelle Long TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long COVID-19PatentsTRIPSTRIPS Flexibilities Getting Serious About Grey Market Imports in the Fight Against COVID-19May 18, 2020 Since the HIV/AIDS pandemic of the 1990s, allowing the importation of generic “grey market” versions…Doris Estelle Long Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19TRIPSTRIPS Flexibilities The Overlooked Role of Copyright in Securing Vaccine Distribution EquitySeptember 6, 2021 As the COVID-19 pandemic continues to ravage the globe, we need to consider every avenue…Doris Estelle Long TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long COVID-19PatentsTRIPSTRIPS Flexibilities Getting Serious About Grey Market Imports in the Fight Against COVID-19May 18, 2020 Since the HIV/AIDS pandemic of the 1990s, allowing the importation of generic “grey market” versions…Doris Estelle Long Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long COVID-19PatentsTRIPSTRIPS Flexibilities Getting Serious About Grey Market Imports in the Fight Against COVID-19May 18, 2020 Since the HIV/AIDS pandemic of the 1990s, allowing the importation of generic “grey market” versions…Doris Estelle Long Search Search Blog Front Page CategoriesCategories Select Category ALL (1) Conferences and Papers (1) COVID-19 (26) Data Exclusivities (5) Deceptive Claims (1) Exhaustion (2) Experimental Use (1) IPAB (1) Patent Pools (2) Patents (18) Right to Health (5) TAMU (1) Trade Policy (6) TRIPS (24) TRIPS Flexibilities (6) Vaccines (6) Voluntary Licenses (1) Archives Archives Select Month July 2022 June 2022 March 2022 December 2021 November 2021 October 2021 September 2021 August 2021 July 2021 May 2021 February 2021 January 2021 December 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 Regular Contributors Doris Estelle Long (13) Srividhya Ragavan (12) Shirin Syed (4) Michael Palmedo (3) Jonathan Kimball (1) Sonal Singh (1) All Authors RECENT POSTS Call For Papers: The Eighth Annual IP Mosaic Conference Working with the Ministerial Decision on TRIPS Ministerial Decision: “TRIPped” the Waiver? Intellectual Property Law and Access to Medicines Named One of the Best New Intellectual Property Books by BookAuthority Omicron: Requires TRIPS Waiver Vaccine
COVID-19PatentsTRIPSTRIPS Flexibilities Getting Serious About Grey Market Imports in the Fight Against COVID-19May 18, 2020 Since the HIV/AIDS pandemic of the 1990s, allowing the importation of generic “grey market” versions…Doris Estelle Long